Acute exposure to progesterone attenuates cardiac contraction by modifying myofilament calcium sensitivity in the female mouse heart

作者：Hirad Feridooni, Jennifer MacDonald, Anjali Ghimire, W. Glen Pyle, Susan E. Howlett · 发表于：American Journal of Physiology-Heart and Circulatory Physiology · 年份：2016 · DOI：10.1152/ajpheart.00073.2016 · 被引用次数：32 · 研究领域：Cardiac electrophysiology and arrhythmias、Cardiovascular Effects of Exercise、Cardiomyopathy and Myosin Studies

Acute application of progesterone attenuates cardiac contraction, although the underlying mechanisms are unclear. We investigated whether progesterone modified contraction in isolated ventricular myocytes and identified the Ca 2+ handling mechanisms involved in female C57BL/6 mice (6–9 mo; sodium pentobarbital anesthesia). Cells were field-stimulated (4 Hz; 37°C) and exposed to progesterone (0.001–10.0 μM) or vehicle (35 min). Ca 2+ transients (fura-2) and cell shortening were recorded simultaneously. Maximal concentrations of progesterone inhibited peak contraction by 71.4% (IC 50 = 160 ± 50 nM; n = 12) and slowed relaxation by 75.4%. By contrast, progesterone had no effect on amplitudes or time courses of underlying Ca 2+ transients. Progesterone (1 µM) also abbreviated action potential duration. When the duration of depolarization was controlled by voltage-clamp, progesterone attenuated contraction and slowed relaxation but did not affect Ca 2+ currents, Ca 2+ transients, sarcoplasmic reticulum (SR) content, or fractional release of SR Ca 2+ . Actomyosin MgATPase activity was assayed in myofilaments from hearts perfused with progesterone (1 μM) or vehicle (35 min). While maximal responses to Ca 2+ were not affected by progesterone, myofilament Ca 2+ sensitivity was reduced (EC 50 = 0.94 ± 0.01 µM for control, n = 7 vs. 1.13 ± 0.05 μM for progesterone, n = 6; P < 0.05) and progesterone increased phosphorylation of myosin binding protein C. The effects on contraction were...